Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greta Varchi

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Journal of Medicinal Chemistry|March 9, 2017
1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer TreatmentClaudia Ferroni, Antonella Pepe, Yeong Sang Kim, et al.
European Journal of Medicinal Chemistry|August 28, 2015
Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeuticsGiovanna Sociali, Lauretta Galeno, Marco Daniele Parenti, et al.
European Journal of Medicinal Chemistry|September 18, 2022
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3Marco Daniele Parenti, Marina Naldi, Elisabetta Manoni, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2024
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistancePaola Sanese, Katia De Marco, Martina Lepore Signorile, et al.
Signal Transduction and Targeted Therapy|June 30, 2025
Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axisMartina Lepore Signorile, Elisabetta Di Nicola, Giovanna Forte, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Journal of Medicinal Chemistry|March 9, 2017
1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer TreatmentClaudia Ferroni, Antonella Pepe, Yeong Sang Kim, et al.
European Journal of Medicinal Chemistry|August 28, 2015
Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeuticsGiovanna Sociali, Lauretta Galeno, Marco Daniele Parenti, et al.
European Journal of Medicinal Chemistry|September 18, 2022
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3Marco Daniele Parenti, Marina Naldi, Elisabetta Manoni, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2024
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistancePaola Sanese, Katia De Marco, Martina Lepore Signorile, et al.
Signal Transduction and Targeted Therapy|June 30, 2025
Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axisMartina Lepore Signorile, Elisabetta Di Nicola, Giovanna Forte, et al.
Pageof 7